Samsung Epis Holdings: Audited Report Restated, Consolidated Net Income Up 30%
-
Consolidated: total assets 3.86T won, equity 2.23T won, net income 509B won (increased from prior)
-
Separate: total assets 3.84T won, equity 2.22T won, net income 495.2B won
-
Auditor opinion 'unqualified' maintained, no going concern uncertainty
-
Subsidiary Samsung Bioepis accounts for 97.03% of assets
-
This report replaces the original report dated March 4, 2026
-
No capital impairment (equity 2.23T vs. capital stock 103.4B)
KOSPI Filing Information
-
Filing: [Correction of Description] Submission of Audit Report (Major Management Matters of Subsidiary)
-
Company: Samsung Epis Holdings (0126Z0)
-
Submission: Samsung Epis Holdings Co., Ltd.
-
Receipt: 05-15-2026
-
Under KRX KOSPI Market Division